Literature DB >> 19265726

Evaluating the role of serotonin in hot flashes after breast cancer using acute tryptophan depletion.

Janet S Carpenter1, Menggang Yu, Jingwei Wu, Diane Von Ah, Jennifer Milata, Julie L Otte, Shelley Johns, Bryan Schneider, Anna Maria Storniolo, Ronald Salomon, Zeuresenay Desta, Donghua Cao, Yan Jin, Santosh Philips, Todd C Skaar.   

Abstract

OBJECTIVE: Among women with breast cancer, hot flashes are frequent, severe, and bothersome symptoms that can negatively impact quality of life and compromise compliance with life-saving medications (eg, tamoxifen and aromatase inhibitors). Clinicians' abilities to treat hot flashes are limited due to inadequate understanding of physiological mechanisms involved in hot flashes. Using an acute tryptophan depletion paradigm, we tested whether alterations in central serotonin levels were involved in the induction of hot flashes in women with breast cancer.
METHODS: This was a within-participant, double-blind, controlled, balanced, crossover study. Twenty-seven women completed two 9-hour test days. On one test day, women ingested a concentrated amino acid drink and encapsulated amino acids (no tryptophan) according to published procedures that have been shown to have specific effects on serotonin within 4.5 to 7 hours. On the other test day, women ingested a control drink. Serial venous blood sampling and objective hot flash monitoring were used to evaluate response to each condition.
RESULTS: Response to acute tryptophan depletion was variable and unexplained by use of selective serotonin reuptake inhibitors, antiestrogens, breast cancer disease and treatment variables, or genetic polymorphisms in serotonin receptor and transporter genes. Contrary to our hypothesis, hot flashes were not worsened with acute tryptophan depletion.
CONCLUSIONS: Physiologically documented and self-reported hot flashes were not exacerbated by tryptophan depletion. Additional mechanistic research is needed to better understand the etiology of hot flashes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19265726      PMCID: PMC2714664          DOI: 10.1097/gme.0b013e318199e9f6

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  69 in total

1.  A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoria.

Authors:  S Steinberg; L Annable; S N Young; N Liyanage
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

Review 2.  The role of serotonin in hot flushes.

Authors:  H H Berendsen
Journal:  Maturitas       Date:  2000-10-31       Impact factor: 4.342

3.  Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group.

Authors:  H Mouridsen; M Gershanovich; Y Sun; R Pérez-Carrión; C Boni; A Monnier; J Apffelstaedt; R Smith; H P Sleeboom; F Jänicke; A Pluzanska; M Dank; D Becquart; P P Bapsy; E Salminen; R Snyder; M Lassus; J A Verbeek; B Staffler; H A Chaudri-Ross; M Dugan
Journal:  J Clin Oncol       Date:  2001-05-15       Impact factor: 44.544

4.  Circadian rhythm of objectively recorded hot flashes in postmenopausal breast cancer survivors.

Authors:  J S Carpenter; S Gautam; R R Freedman; M Andrykowski
Journal:  Menopause       Date:  2001 May-Jun       Impact factor: 2.953

5.  Plasma Trp/LNAA ratio increases during chronic ingestion of an alpha-lactalbumin diet in rats.

Authors:  S Feurté; K Gerozissis; A Regnault; F M Paul
Journal:  Nutr Neurosci       Date:  2001       Impact factor: 4.994

Review 6.  The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels.

Authors:  Simon N Young; Marco Leyton
Journal:  Pharmacol Biochem Behav       Date:  2002-04       Impact factor: 3.533

Review 7.  Tryptophan depletion and its implications for psychiatry.

Authors:  C Bell; J Abrams; D Nutt
Journal:  Br J Psychiatry       Date:  2001-05       Impact factor: 9.319

8.  Genetic evaluation of the serotonergic system in chronic fatigue syndrome.

Authors:  Alicia K Smith; Irina Dimulescu; Virginia R Falkenberg; Supraja Narasimhan; Christine Heim; Suzanne D Vernon; Mangalathu S Rajeevan
Journal:  Psychoneuroendocrinology       Date:  2008-02       Impact factor: 4.905

9.  Modeling the hot flash experience in breast cancer survivors.

Authors:  Janet S Carpenter; Kevin L Rand
Journal:  Menopause       Date:  2008 May-Jun       Impact factor: 2.953

10.  Effect of serotonin receptor 2A gene polymorphism on mirtazapine response in major depression.

Authors:  Rhee-Hun Kang; Myoung-Jin Choi; Jong-Woo Paik; Sang-Woo Hahn; Min-Soo Lee
Journal:  Int J Psychiatry Med       Date:  2007       Impact factor: 1.210

View more
  7 in total

1.  Evaluating the role of serotonin on neuropsychological function after breast cancer using acute tryptophan depletion.

Authors:  Diane Von Ah; Todd Skaar; Fredrick Unverzagt; Menggang Yu; Jingwei Wu; Bryan Schneider; Anna Maria Storniolo; Lyndsi Moser; Kristin Ryker; Jennifer Milata; Janet S Carpenter
Journal:  Biol Res Nurs       Date:  2010-12-30       Impact factor: 2.522

2.  Long-term chinese herbs decoction administration for management of hot flashes associated with endocrine therapy in breast cancer patients.

Authors:  Dong Xue; Hong Sun; Ping-Ping Li
Journal:  Chin J Cancer Res       Date:  2011-03       Impact factor: 5.087

3.  Escitalopram treatment of menopausal hot flashes.

Authors:  Robert R Freedman; Michael L Kruger; Manuel E Tancer
Journal:  Menopause       Date:  2011-08       Impact factor: 2.953

4.  How are Interactions Taken into Account in Studies on Conventional and Complementary Therapies for Breast Cancer Patients with Menopausal Complaints?

Authors:  J Hübner; K Münstedt; R Mücke; O Micke
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-10       Impact factor: 2.915

Review 5.  Risk factors, pathophysiology, and treatment of hot flashes in cancer.

Authors:  William I Fisher; Aimee K Johnson; Gary R Elkins; Julie L Otte; Debra S Burns; Menggang Yu; Janet S Carpenter
Journal:  CA Cancer J Clin       Date:  2013-01-25       Impact factor: 508.702

6.  Designing cost-efficient randomized trials by using flexible recruitment strategies.

Authors:  Menggang Yu; Jingwei Wu; Debra S Burns; Janet S Carpenter
Journal:  BMC Med Res Methodol       Date:  2012-07-24       Impact factor: 4.615

Review 7.  Phytochemicals modulate carcinogenic signaling pathways in breast and hormone-related cancers.

Authors:  Roxana Cojocneanu Petric; Cornelia Braicu; Lajos Raduly; Oana Zanoaga; Nicolae Dragos; Paloma Monroig; Dan Dumitrascu; Ioana Berindan-Neagoe
Journal:  Onco Targets Ther       Date:  2015-08-06       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.